在HCC中,m6A修饰和非编码RNA之间的交叉交叉.
Zitong Qiu1, Xingxing Yuan2, Xinyue Wang3
1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, PR China.
Cellular signalling
|February 3, 2024
概括
N6-甲基氨酸 (m6A) RNA 修饰和非编码RNA (ncRNA) 交叉对肝细胞癌 (HCC) 进展和耐药性产生重大影响. 了解这种相互作用为HCC治疗提供了新的预后标志物和治疗点.
科学领域:
- 分子瘤学分子瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 在RNA生物学,RNA生物学.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因,具有复杂的潜在分子机制.
- N6-甲基氨酸 (m6A) RNA修饰调节基因表达和RNA代谢,受甲基酶和脱甲基酶的影响.
- 非编码RNAs (ncRNAs) 在瘤发育中发挥关键作用,包括表观遗传调节和mRNA转录.
研究的目的:
- 审查m6ARNA修饰和ncRNAs在肝细胞癌 (HCC) 发病过程中的复杂相互作用.
- 阐明m6A-ncRNA交叉对HCC进展,恶性表型和耐药性的作用.
- 探索m6A-ncRNA相互作用作为潜在的预后标记物和HCC的治疗点的临床影响.
主要方法:
- 文献综述总结了当前关于m6A修饰和ncRNAs在HCC中的研究.
- 对调查m6A-ncRNA交叉的功能作用在HCC发育和耐药性方面的研究进行分析.
- 综合与m6A-ncRNA相互作用作为生物标志物和治疗策略的临床实用性相关的发现.
主要成果:
- m6A-ncRNA相互作用与HCC恶性进展有显著的关系.
- 这种交叉语音是导致HCC药物耐药性的关键因素.
- 特定的m6A-ncRNA模式与HCC表型和患者结局相关.
结论:
- 在m6ARNA修饰和ncRNAs之间的交叉是HCC进展和治疗反应的关键决定因素.
- 准m6A-ncRNA相互作用为开发新型预后生物标志物和HCC有效治疗策略提供了一个有希望的途径.
- 对m6A-ncRNA调控网络的进一步研究对于推进HCC治疗至关重要.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
Chromatin Structure Regulates pre-mRNA Processing
7.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.0K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K


